Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory Reaman

Showing results (21-30 of 83) with videos related to

Pageof 9
Sort By:
Pediatric Blood & Cancer|July 29, 2009
A phase II study of Campath-1H in children with relapsed or refractory acute lymphoblastic leukemia: a Children's Oncology Group reportAnne L Angiolillo, Alice L Yu, Gregory Reaman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 18, 2020
Accelerating the Global Development of Pediatric Cancer Drugs: A Call to Coordinate the Submissions of Pediatric Investigation Plans and Pediatric Study Plans to the European Medicines Agency and US Food and Drug AdministrationGregory Reaman, Dominik Karres, Franca Ligas, et al.
Therapeutic Innovation & Regulatory Science|September 9, 2021
Common Commentary on Paediatric Oncology Drug Development Published: Another Step in Optimising Global Regulatory Coordination of Paediatric Development PlansDominik Karres, Gregory Reaman, Franca Ligas, et al.
The Lancet. Child & Adolescent Health|June 5, 2019
Interventions for cisplatin-induced hearing loss in children and adolescents with cancerDavid R Freyer, Penelope Brock, Kristin Knight, et al.
The Lancet. Child & Adolescent Health|August 22, 2020
The RACE to accelerate drug development for children with cancerAndrew D J Pearson, Dominik Karres, Gregory Reaman, et al.
Clinical Pharmacology and Therapeutics|December 12, 2017
Pediatric Development of Molecularly Targeted Oncology DrugsShivam Kamlesh Patel, Ruby Leong, Hong Zhao, et al.
Cancer Medicine|October 23, 2021
Intercontinental collaboration in clinical trials for children and adolescents with cancer-A systematic review by ACCELERATETeresa de Rojas, Andrew J Pearson, Nicole Scobie, et al.
Pediatric Blood & Cancer|May 5, 2012
Implementation of multi-site neurocognitive assessments within a pediatric cooperative group: can it be done?Leanne Embry, Robert D Annett, Alicia Kunin-Batson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 20, 2005
Phase I clinical and pharmacokinetic study of flavopiridol in children with refractory solid tumors: a Children's Oncology Group StudyJames A Whitlock, Mark Krailo, Joel M Reid, et al.
Pediatric Blood & Cancer|June 20, 2017
U.S. Food and Drug Administration approval summary: Eltrombopag for the treatment of pediatric patients with chronic immune (idiopathic) thrombocytopeniaLori A Ehrlich, Virginia E Kwitkowski, Gregory Reaman, et al.
Pageof 9

Showing results (21-30 of 83) with videos related to

Sort By:
Pageof 9
Pediatric Blood & Cancer|July 29, 2009
A phase II study of Campath-1H in children with relapsed or refractory acute lymphoblastic leukemia: a Children's Oncology Group reportAnne L Angiolillo, Alice L Yu, Gregory Reaman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 18, 2020
Accelerating the Global Development of Pediatric Cancer Drugs: A Call to Coordinate the Submissions of Pediatric Investigation Plans and Pediatric Study Plans to the European Medicines Agency and US Food and Drug AdministrationGregory Reaman, Dominik Karres, Franca Ligas, et al.
Therapeutic Innovation & Regulatory Science|September 9, 2021
Common Commentary on Paediatric Oncology Drug Development Published: Another Step in Optimising Global Regulatory Coordination of Paediatric Development PlansDominik Karres, Gregory Reaman, Franca Ligas, et al.
The Lancet. Child & Adolescent Health|June 5, 2019
Interventions for cisplatin-induced hearing loss in children and adolescents with cancerDavid R Freyer, Penelope Brock, Kristin Knight, et al.
The Lancet. Child & Adolescent Health|August 22, 2020
The RACE to accelerate drug development for children with cancerAndrew D J Pearson, Dominik Karres, Gregory Reaman, et al.
Clinical Pharmacology and Therapeutics|December 12, 2017
Pediatric Development of Molecularly Targeted Oncology DrugsShivam Kamlesh Patel, Ruby Leong, Hong Zhao, et al.
Cancer Medicine|October 23, 2021
Intercontinental collaboration in clinical trials for children and adolescents with cancer-A systematic review by ACCELERATETeresa de Rojas, Andrew J Pearson, Nicole Scobie, et al.
Pediatric Blood & Cancer|May 5, 2012
Implementation of multi-site neurocognitive assessments within a pediatric cooperative group: can it be done?Leanne Embry, Robert D Annett, Alicia Kunin-Batson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 20, 2005
Phase I clinical and pharmacokinetic study of flavopiridol in children with refractory solid tumors: a Children's Oncology Group StudyJames A Whitlock, Mark Krailo, Joel M Reid, et al.
Pediatric Blood & Cancer|June 20, 2017
U.S. Food and Drug Administration approval summary: Eltrombopag for the treatment of pediatric patients with chronic immune (idiopathic) thrombocytopeniaLori A Ehrlich, Virginia E Kwitkowski, Gregory Reaman, et al.
Pageof 9